ESC Premium Access

Real-world analysis exploring the association between anti-hypertensive therapy with perindopril-based single-pill combinations (SPC) and cardiovascular outcomes and all-cause mortality in Italy

Congress Presentation

About the speakers

Associate Professor Jacek Wolf

Medical University of Gdansk, Gdansk (Poland)
0 follower

Doctor Stefano Masi

University of Pisa, Pisa (Italy)
5 presentations
0 follower

7 more presentations in this session

Systolic plood pressure response to ASi BI 690517 with and without empagliflozin in CKD

Speaker: Professor P. Rossing (Herlev, DK)

Thumbnail

Adherence to anti-hypertensive therapy with perindopril-based single-pill versus free-pill combinations: a 10-year real-world analysis in Italy

Speaker: Associate Professor A. Vintila (Bucharest, RO)

Thumbnail

The expanding role of semaglutide in cardiovascular disease and its the effect on blood pressure

Speaker: Doctor C. Kennedy (Dublin, IE)

Thumbnail

Injectable angiotensinogen inhibition therapy for hypertension: a systematic review and meta-analysis

Speaker: Doctor A. Yadav (New Delhi, IN)

Thumbnail

A higher adherence to perindopril-based anti-hypertensive therapy is associated with a reduced risk of cardiovascular outcomes and all-cause mortality in real clinical practice in Italy

Speaker: Doctor S. Masi (Pisa, IT)

Thumbnail

Access the full session

Hypertension management: drugs

Speakers: Associate Professor J. Wolf, Doctor S. Masi, Professor P. Rossing, Associate Professor A. Vintila, Doctor C. Kennedy...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations